{"organizations": [], "uuid": "dae17281ba416cb7450c6345c6410be0f0b0ce38", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180508.html", "section_title": "Archive News &amp; Video for Tuesday, 08 May 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-bio-rad-q1-earnings-per-share-2177/brief-bio-rad-q1-earnings-per-share-21-77-idUSASC0A0QO", "country": "US", "domain_rank": 408, "title": "BRIEF-Bio-Rad Q1 Earnings Per Share $21.77", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T05:46:00.000+03:00", "replies_count": 0, "uuid": "dae17281ba416cb7450c6345c6410be0f0b0ce38"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-bio-rad-q1-earnings-per-share-2177/brief-bio-rad-q1-earnings-per-share-21-77-idUSASC0A0QO", "ord_in_thread": 0, "title": "BRIEF-Bio-Rad Q1 Earnings Per Share $21.77", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "rad laboratories inc", "sentiment": "negative"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 8 (Reuters) - Bio Rad Laboratories Inc:\n* BIO-RAD REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* Q1 NON-GAAP EARNINGS PER SHARE $1.17\n* Q1 EARNINGS PER SHARE $21.77 * Q1 SALES $551.5 MILLION VERSUS I/B/E/S VIEW $527.2 MILLION\n* Q1 EARNINGS PER SHARE VIEW $1.07 â€” THOMSON REUTERS I/B/E/S\n* BIO RAD LABORATORIES - FOR 2018, CONTINUES TO ANTICIPATE CURRENCY-NEUTRAL REVENUE GROWTH OF APPROXIMATELY 3.5 TO 4.0 PERCENT\n* BIO RAD - FOR 2018, CONTINUES TO ANTICIPATE IMPROVED PROFITABILITY WITH A CURRENCY- NEUTRAL GAAP OPERATING MARGIN TARGET OF 10 PERCENT Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-05-09T05:46:00.000+03:00", "crawled": "2018-05-09T12:35:20.026+03:00", "highlightTitle": ""}